The Number of Gene Mutations Doesn't Matter—Yet!
In the wake of the Human Genome Project, researchers bring us a steady flow of news about newly discovered genetic mutations seen in various cancers. This raises hope for targeted therapies with fewer side effects that can effectively beat back the cancer you or a loved one may have. But how hopeful should we be in the short-term? Dr. Charles Schiffer, a respected expert from the Barbara Ann Karmanos Cancer Institute at Wayne State University in Detroit says it can be a long road from the discovery of a gene to the availability of an effective medicine. In an interview with Patient Power's Andrew Schorr, he puts genetic discoveries in perspective for cancer patients.
Experts & Guests
Charles Schiffer, M.D.
Professor of Medicine and Oncology, Barbara Ann Karmanos Cancer InstituteDr. Schiffer received his undergraduate degree from Brandeis University and his medical degree from New York University School of Medicine. He stayed on at NYU, completing his internship and residency in Internal Medicine at Bellevue Hospital, where he was Chief Resident. Dr. Schiffer is board certified in Internal Medicine and Medical Oncology. Before assuming his current position at Wayne State... more >